Ahren Acquisition appoints Jonathan Roney to its Board as Independent Director

– CAYMAN ISLANDS, Grand Cayman –  Ahren Acquisition Corp. (Nasdaq: AHRN) today announced the appointment of Jonathan Roney to its Board as an independent director, effective on April 8, 2022.

About Jonathan Roney

Jonathan Roney is a fund director at Paradigm Governance Partners, a Cayman Islands governance and fiduciary services provider, and acts as a professional independent director for hedge funds, private equity funds, and investment management companies. He has acted as a director for Cayman Islands companies for more than 10 years and has more than 20 years of experience in the financial services industry. He has extensive experience and knowledge of fund governance, operations, administration, and regulatory risk management.

Mr. Roney is a Professional Director registered under the Cayman Islands Directors Registration and Licensing Act 2014. He is also a fellow of the Institute of Chartered Accountants in England and Wales, has a bachelor’s degree in Biochemistry from Imperial College, London and is a member of the Cayman Islands Directors Association.

About Ahren Acquisition Corp.

Ahren Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company’s efforts to identify a prospective initial business combination target are initially focused on high growth, domain leading companies fueled by breakthrough deep technology and/or deep science. The Company believes that it is well-positioned to pursue initial business combination opportunities within its four domains of interest: Planet & Efficient Energy; Brain & Artificial Intelligence; Genetics & Platform Technologies; and Space, Robotics & Physics.

The Company’s sponsor is AACS LP, which is an affiliate of Ahren LP. Ahren is an investment fund that seeks to make transformative investments in companies that can penetrate large markets within and among the Company’s four domains of interest and on a global stage. Ahren was founded in 2017 by technology and disruptive healthcare investor and Founding & General Partner Alice Newcombe-Ellis, alongside co-founding Science Partners that have founded companies and/or whose inventions and technologies are today valued in excess of $100 billion combined. Alice Newcombe-Ellis acts as the Company’s Chief Executive Officer.

For more information: https://ahrenacq.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team